![International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-05163-5/MediaObjects/259_2020_5163_Fig1_HTML.png)
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios
Transcatheter arterial embolization of acute bleeding as 24/7 service: predictors of outcome and mortality
![PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system](https://i1.rgstatic.net/publication/305483669_Y90_Radioembolization_in_chemo-refractory_metastastic_liver_dominant_colorectal_cancer_patients_Outcome_assessment_applying_a_predictive_scoring_system/links/5fc21285458515b7977cb31d/largepreview.png)
PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system
![PDF) Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival PDF) Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival](https://i1.rgstatic.net/publication/327568934_Local_ablation_or_radioembolization_of_colorectal_cancer_metastases_comorbidities_or_older_age_do_not_affect_overall_survival/links/5fc216d992851c933f6a8c28/largepreview.png)
PDF) Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
![Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine](https://www.researchgate.net/publication/351042179/figure/tbl1/AS:1022432219504640@1620778245821/Toxicity-analysis_Q320.jpg)
Max SEIDENSTICKER | Senior Physician | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU | Clinic for Radiology and Nuclear Medicine
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
![Otto-von-Guericke University of Magdeburg | Department of Gastroenterology, Hepatology & Infectious Diseases - Academia.edu Otto-von-Guericke University of Magdeburg | Department of Gastroenterology, Hepatology & Infectious Diseases - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45059867/mini_magick20190213-26716-cncemd.png?1550058430)
Otto-von-Guericke University of Magdeburg | Department of Gastroenterology, Hepatology & Infectious Diseases - Academia.edu
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
![PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy](https://i1.rgstatic.net/publication/260154604_Safety_of_Repeated_Radioembolizations_in_Patients_with_Advanced_Primary_and_Secondary_Liver_Tumors_and_Progressive_Disease_After_First_Selective_Internal_Radiotherapy/links/564c980508ae3374e5e051ed/largepreview.png)
PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy
Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sora
![Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-016-2549-x/MediaObjects/12885_2016_2549_Fig3_HTML.gif)
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
![PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation](https://i1.rgstatic.net/publication/334646218_Superficial_skin_cancer_therapy_with_Y-90_microspheres_A_feasibility_study_on_patch_preparation/links/5d381247a6fdcc370a5a6c97/largepreview.png)